Grant to Automate Variant Interpretation and Create Platform for Sharing Micropublications Across the Genomics Community
Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s further innovation in automating aspects of genomic interpretation from the research literature, and the creation of a platform for producing and sharing “micropublications” across the genomics community.
Micropublications are designed to rapidly place research findings and reviews in the public domain. Curated genomic variant interpretation can be made more efficient if findings and reviews can be rapidly published and shared across the research and clinical community. The grant funds Genomenon’s work to automatically organize the information relevant to genomic classification, along with conclusive content from scientific references, publish the findings, and share the information in a public format.
Importantly, the aim is to allow users to modify and keep up to date the micropublication as new research is published in the field so the findings are always up to date.
“This grant allows us to build on the work from our last successful NIH funding to increase the automation of variant interpretation and allow users to rapidly share their findings across the scientific community.” said Genomenon’s Co-founder and CSO, Dr. Mark Kiel. “This automated micropublication platform will help accelerate the sharing of knowledge as more and more genomic research is being published every year.
* Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R43HG010446. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Genomenon connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases.
Their flagship product, the Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield and assure repeatability in reporting genetic testing results.
They license their Mastermind Curated Genomic Datasets to pharmaceutical and bio-pharma companies to inform precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.